Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07722234
NA

Clinical Practice of Hydromorphone in Multimodal Analgesia for Enhanced Recovery After Surgery (ERAS) in Knee Arthroplasty

Sponsor: China-Japan Friendship Hospital

View on ClinicalTrials.gov

Summary

This study proposes a multimodal analgesia regimen comprising preoperative non-steroidal anti-inflammatory drugs (NSAIDs) for preemptive analgesia, intra-articular injection at the end of surgery, and postoperative adductor canal block. The objective is to observe the analgesic efficacy and duration of hydromorphone combined with ropivacaine in the adductor canal block on resting and movement-related pain in patients following total knee arthroplasty, as well as the time to recovery from motor blockade and the incidence of drug-related adverse events.

Official title: Hydromorphone as an Adjuvant to Ropivacaine for Adductor Canal Block in Total Knee Arthroplasty: A Prospective, Randomized, Double-Blind, Controlled Trial

Key Details

Gender

All

Age Range

60 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2026-03-10

Completion Date

2026-06-13

Last Updated

2026-07-23

Healthy Volunteers

No

Interventions

DRUG

Ropivacaine + Hydromorphone

Ultrasound-guided single-shot ACB with a 20 mL mixture of 0.5% ropivacaine and 0.5 mg hydromorphone

DRUG

Ropivacaine

Ultrasound-guided single-shot adductor canal block (ACB) with 20 mL of 0.5% ropivacaine

Locations (1)

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China